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Summary
Objective: To quantify the expression of genes encoding extracellular matrix (ECM) proteins in human cartilage from normal and
osteoarthritic (OA) joints.
Design: Human cartilage samples were classified as control (CTR) or OA according to clinical evaluation and assessed histologically and
biochemically to confirm the diagnosis. mRNAs encoding collagen types I, II and X, aggrecan, versican, osteopontin and osteocalcin were
quantified by real-time reverse transcription-PCR assays and normalized to a reference mRNA (GAPDH).
Results: RNA from native cartilage could be reproducibly and efficiently amplified by real-time PCR only if isolated using purification
membranes. Primers and fluorescent probes for real-time PCR, endowed with comparable (<6% difference from GAPDH) and high (>91%)
amplification efficiencies, were designed and validated for the selected ECM genes. The expression of most genes under investigation
displayed large variations and was not significantly different in CTR and OA cartilage. Only osteopontin mRNA levels were significantly higher
in OA than CTR specimens. mRNA ratios of collagen type II to I and of aggrecan to versican, defined as indexes of chondrocyte
differentiation, were less variable within each population than the single genes and markedly higher (27.0 and 7.6-fold, respectively) in CTR
than OA cartilage, with high statistical significance (P=0.00013 and P=0.00007, respectively).
Conclusions: Our results provide evidence that gene patterns related to chondrocyte differentiation discriminate between CTR and OA
human cartilage with higher sensitivity than single ECM genes. The method described here has the potential to improve understanding of
the progression of OA and could become a valuable diagnostic tool. © 2001 OsteoArthritis Research Society International
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The unique mechanical properties of articular cartilage
depend on the composition and organization of its extra-
cellular matrix (ECM). It is generally agreed that the pro-
gressive functional failure of cartilage in osteoarthrosis
(OA) is not only due to enhanced degradation of the main
tissue components (e.g. type II collagen and aggrecan), but
also to discoordinate changes in the types and amounts of
newly synthesized ECM molecules1. Thus, investigation of
OA chondrocyte anabolic activity by quantification of the
expression of mRNAs encoding specific ECM molecules
should help understand the progression of the pathology,
and may ultimately improve its diagnosis and treatment.
Despite the wealth of knowledge on the structure of
different cartilage ECM molecules and their genes, there is
relatively little and sometimes contradictory information on
the quantitation of their expression in normal and OA
articular cartilage. It was reported that mRNAs for collagen
types I and X are absent in normal adult cartilage and that
collagen types II and X, but not I, are consistently
up-regulated in specific layers of OA tissue2–6. However,
independent studies performed using the same technique
(i.e. in situ hybridization) reported that collagen type II
mRNA was detectable in only about 50% of the processed112OA cartilage samples7, and that collagen type I was
abundantly expressed by chondrocytes of deep zones of
OA fibrocartilaginous tissue8. Also the expression of differ-
ent types of proteoglycans, investigated using a competi-
tive PCR technique, was not always consistent when
different sets of samples were used9,10.
The discordance among the different studies could be
due not only to variability among different individuals, but
also to limitations inherent to the techniques used. Northern
blotting and in-situ hybridization methods are not sensi-
tive enough to detect low-level gene expression and not
accurate enough to quantify the full range of expression. An
amplification step may therefore be required to quantify
mRNA amounts from limited tissue biopsies. However,
quantification of mRNA using conventional PCR techniques
may be of limited accuracy, both because of the detection
method used (i.e. semi-quantitative image analysis), and
because analysis is often performed using a constant
number of amplification cycles, after which the system
could be in a saturation phase.
Recently, real-time PCR has enabled the quantification
of mRNA with high accuracy, reproducibility and sensitivity
in a wide dynamic range, without the need of post-PCR
processing11. In this paper, we developed and vali-
dated real-time PCR assays to quantify the expression of
genes encoding the most abundant molecules in the ECM
of normal articular cartilage (i.e. collagen type II and
aggrecan) and of degenerated fibrocartilage (i.e. collagen
type I and versican), as well as of typical markers
of chondrocyte hypertrophy (i.e. collagen type X and
Osteoarthritis and Cartilage Vol. 9 No. 2 113osteopontin) and of bone cells (i.e. osteocalcin). Our
hypothesis was that real-time PCR can lead to the identifi-
cation of quantitative patterns of ECM gene expression,
typical for normal and OA adult human cartilage tissue.Methods
PATIENTS AND SAMPLESPatient’s characteristics
Human articular OA cartilage was obtained from femoral
heads, femoral condyles, and tibial plateaus of patients
operated for knee, hip or ankle replacement (10 individuals;
mean age 68.4, range 55–87) in the University Hospital of
Basel. The diagnosis of OA was based on clinical and
radiographic evaluations, according to standard criteria12.
Control (CTR) cartilage samples (seven individuals; mean
age 59.3, range 25–85) were collected from the hip or ankle
of patients with no history of joint disease, undergoing
joint replacement following femoral neck fracture or foot
amputation for tumor resection.Cartilage specimens
Non-calcified cartilage (i.e. superficial, middle, and deep
layers above the tidemark)3. was dissected from the bone
immediately after surgery. Pieces of cartilage were
obtained from the weight-bearing area of the joints, which
was macroscopically degenerated in OA patients, and
processed for the different assays as follows. Samples
were fixed in 4% buffered formalin at 4°C for 24 h for
histological analysis, frozen in pre-weighed vials for
biochemical assessment, or homogenized in Trizol (Life
Technologies, Basel, Switzerland) for mRNA quantitation.
Some samples were also fixed in acetone at 4°C for
10 min, or digested with 0.15% collagenase for 22 h to
isolate primary chondrocytes.Osteoblast isolation
Bone chips from the iliac crest of patients undergoing
spinal fusion were cultured in Petri dishes in medium
supplemented with 10% fetal bovine serum, ascorbic acid,
dexamethasone and beta-glycerophosphate. After 10 days,
outgrown cells were collected and homogenized in Trizol
for mRNA analysis and served as controls for the
expression of bone-specific proteins.HISTOLOGICAL ANALYSIS
Fixed samples were dehydrated, embedded in paraffin,
and cut into 5 m sections. Cartilage slices were cut
vertically from the surface to the bottom. Sections, stained
with safranin O for sulfated glycosaminoglycans (GAG),
were evaluated based on the Mankin’s score by three
independent experienced observers13.BIOCHEMICAL ANALYSES
Samples for biochemical analyses were frozen, lyo-
philized, and digested with proteinase K in the presence of
protease inhibitors14. Briefly, 10–40 mg dry weight of
sample were digested with 1 ml proteinase K solution(1 mg/ml) containing 50 mM Tris, 1 mM EDTA, 1 mM iodo-
acetamide, and 10 g/ml pepstatin A at 56°C for 15 h.
Proteinase K was then inactivated by boiling the digest for
12 min. The GAG content was determined spectrophoto-
metrically using dimethylmethylene blue dye and bovine
chondroitin sulfate as a standard15. Collagen type II was
quantified using a monoclonal antibody-based inhibition
ELISA14.REAL-TIME QUANTITATIVE PCRTheoretical basis
Real-time quantitative PCR monitors the degradation of
a sequence-specific, dual-labeled fluorescent probe after
each cycle of PCR amplification. During the extension
phase, the 5′-exonuclease activity of Taq DNA polymerase
cleaves the probe, separating the 5′-reporter fluorescent
dye from the 3′-quencher fluorescent dye, resulting in an
increase in the emission spectra of the reporter fluorescent
dye. After subtraction of the background fluorescence,
calculated during the first 15 amplification cycles, the
measured fluorescence is graphed as an amplification plot.
Each reaction is characterized by a value, Ct, defined as
the fractional number of cycles at which the reporter
fluorescent emission reaches a fixed threshold level in the
exponential region of the amplification plot. The Ct value is
correlated to input target mRNA amount: a larger starting
quantity of mRNA target results in a lower number of PCR
cycles required for the reporter fluorescent emission to
reach the threshold, and therefore a lower Ct value. Thus,
the method is not based on the measurement of the total
amount of amplified product after a fixed number of cycles,
as in conventional PCR, and does not require post-PCR
processing of the product11.Primers and probes
Primers and probes for human GAPDH, collagen types I,
II, and X, aggrecan, versican, osteopontin and osteocalcin
were designed with the assistance of the Primer Express
computer program (Perkin-Elmer Applied Biosystems,
Foster City, CA), in order to display minimal internal struc-
ture (i.e. primer–dimer formation) and similar melting tem-
peratures. The total gene specificity of the nucleotide
sequences chosen for the primers and probes was con-
firmed by BLASTN searches (GenBank database
sequences). To avoid non-specific fluorescent emission
derived from the recognition of contaminating genomic
DNA by the probe, the middle third of the probe was placed
at the junction between two exons. The nucleotide
sequences of the oligonucleotide hybridization primers and
probes are shown in Table I. Primers were purchased from
Microsynth (Balgach, Switzerland) and probes were from
Perkin-Elmer Applied Biosystems or Eurogentech (Seraing,
Belgium). Optimal concentrations for the designed primers
and probes were determined as the lowest ones giving the
highest fluorescence levels and the lowest Ct values. The
efficiency of the amplification for each target gene was
assessed as follows. Ct values were measured after serial
dilutions of the cDNA template. The amplification efficiency
was calculated as the slope of the best linear fit of the
expected increase in Ct (i.e. the logarithm in base 2 of the
dilution factor) plotted vs the measured increase in Ct. A
slope of 1 would correspond to one additional cycle
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Osteoarthritis and Cartilage Vol. 9 No. 2 115required to reach the threshold after a 1:2 dilution,
indicating a 100% efficiency.Total RNA extraction and cDNA synthesis
Freshly harvested cartilage (100 mg of tissue chopped in
2–3 mm chunks) was homogenized using a power tissue
homogenizer (Politron PT 1200, Kinematica AG, CH) in
1 ml of Trizol Reagent and processed according to three
different protocols, as follows.
Protocol 1: RNA was isolated using the standard single-
step acid-phenol guanidinium method16.
Protocol 2: After precipitation in isopropyl alcohol
according to protocol 1, RNA was resuspended in 50 l
0.5% SDS and purified with a second extraction with
Phenol/ Chloroform/Isoamyalcohol16.
Protocol 3: After centrifugation with chloroform, the RNA
phase was mixed with an equal amount of 70% ethanol,
and precipitated by application to silica-gel-based mem-
branes (RNeasy® Mini Kit, Qiagen, Basel, CH) according to
the manufacturers’ instructions.
All the RNA samples were finally redissolved in 30 l
water and stored at −25°C. In some cases, RNA was also
isolated from formalin and acetone-fixed cartilage speci-
mens. cDNA was generated from 2 g of RNA by using
murine MLV reverse transcriptase (BRL, Gaithersville, MD)
in the presence of dNTPs and DTT, according to the
manufacturers’ instructions.PCR amplification and analysis
PCR reactions were performed and monitored using a
ABI Prism 7700 Sequence Detection System (Perkin-Elmer
Applied Biosystems). The PCR master mix was based on
AmpliTaq Gold DNA polymerase (Perkin-Elmer Applied
Biosystems). cDNA samples (2.5 l in a total of 25 l per
well) were analysed in duplicate or triplicate. Primers and
probes were used at concentrations ranging from 50 to
900 nM. After an initial denaturation step at 95°C for
10 min, the cDNA products were amplified with 45 PCR
cycles, consisting of a denaturation step at 95°C for 15 s
and an extension step at 60°C for 1 min. Data analysis was
carried out by using the Sequence Detector V program
(Perkin-Elmer Applied Biosystems). For each sample, the
Ct value was determined as the cycle number at which the
fluorescence intensity reached 0.05; this value was chosen
after confirming that in this range all curves were in the
exponential phase of amplification. For each cDNA sample,
the Ct value of each target sequence was subtracted to the
Ct value of the reference gene (GAPDH), to derive Ct.
The level of expression of each target gene, normalized to
GAPDH, was then calculated as (1+Et)Ct, where Et is the
efficiency of amplification of the target sequence. The
resulting values, although normalized to GAPDH, are still
dependent on the efficiency of the mechanism of probe
cleavage and fluorescence emission (PE-ABI; Sequence
Detector User Bulletin 2). Therefore, the reported figures
cannot be considered as absolute expression levels of the
genes of interest, and can only be used for comparative
analyses among samples. GAPDH was chosen as the
reference housekeeping gene based on the majority of
previous studies on chondrocyte gene expression. Since
collagen type II and aggrecan are the typical markers of
differentiated chondrocytes in hyaline cartilage, as opposed
to collagen type I and versican, which are expressed bydedifferentiated chondrocytes and in fibrocartilage, we
defined the ratios of mRNA levels of collagen type II to I
(CII/CI) and of aggrecan to versican (Agg/Ver) as ‘differen-
tiation indexes’ related to the expression of collagens and
proteoglycans, respectively.STATISTICAL ANALYSIS
Differences between CTR and OA cartilage specimens
were assessed by one-way analysis of variance (ANOVA).
Values of P<0.02 were considered to indicate statistically
significant differences.ResultsDEVELOPMENT AND VALIDATION OF THE REAL-TIME PCR ASSAYS
Sequences for the designed primers and probes, the
size of the amplicons, and the position of the exon-to-exon
junctions within the probe are presented in Table I. The
optimal concentrations of the primers and probes, as well
as the specificity and efficiency of the amplifications, were
determined using total RNA samples isolated from human
primary chondrocytes and osteoblasts according to Proto-
col 1. For each target gene, the amplification product
of positive controls revealed a single band at a level
corresponding to the expected size of the amplicon (data
not shown). The measured fluorescence after each ampli-
fication cycle showed typical profiles: the emitted signal
remained at baseline levels during early cycles, then
increased exponentially when sufficient hybridization probe
had been cleaved, and reached a plateau phase at high
cycle numbers [Fig. 1(A)]. The linear correlation between
the Ct values and the initial cDNA amounts, diluted up to
128-fold, confirmed the accuracy of the method in a wide
working range [Fig. 1(B)]. The amplification efficiencies for
each target sequence (Et), calculated from serial dilutions
of cDNA as shown in Fig. 1(C), are reported in Table I.
Since Et values were high (>0.91) and comparable for all
target genes (<6% difference with respect to GAPDH), in
subsequent experiments we approximated Et constants to
1 and therefore calculated the expression of each gene
normalized to GAPDH according to the formula 2Ct
(PE-ABI; Sequence Detector User Bulletin 2).
For samples of native cartilage tissue, the amount of
RNA isolated according to protocol 1 was poor and its purity
not acceptable (i.e. OD260/OD280 values lower than 1.0).
Using an additional purification step according to protocol
2, the RNA yield and the purity index improved (approxi-
mately 1.5), but the amplification of target sequences by
PCR was highly inefficient (data not shown). Protocol 3
(purification on silica-gel-based membranes) enabled iso-
lation of significant amounts of RNA (approximately 20 ng
per mg of tissue), with high purity index (approximately
2.0), which could be amplified by real-time PCR with high
reproducibility and efficiency, yielding amplification curves
comparable to those described for RNA extracted from
cells.
For some cartilage specimens, in which mRNA was
extracted both from the intact tissue and from cells after
tissue digestion, PCR analysis showed that the expression
of all the genes of interest was markedly and differentially
affected by tissue digestion, with differences up to 10–15
fold. RNA isolated from formalin fixed cartilage tissue could
not be amplified by PCR, whereas fixation in acetone
allowed efficient RNA extraction and PCR amplification.
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CTR cartilage samples showed few microscopic
changes, mostly related to reduction of safranin O staining,
and the scores ranged from 0.3 to 3.3 [Table II(A)]. The
specimens from different OA patients displayed consider-
able variability in their histological appearance, ranging
from surface irregularities to marked fibrillation, from cell
cloning to hypocellularity, and from moderate reduction to
complete absence of safranin O staining. Repair tissue was
never observed in the samples processed in this study. The
distribution of Mankin’s histological scores ranged from 4.0
to 8.3 [Table II(A)].
The wet weight fractions of water, GAG and type II
collagen of the cartilage specimens are presented in
Table II(B). The water content was significantly higher in
OA than in CTR cartilage, whereas the GAG and type II
collagen fractions of wet weight were higher in CTR
cartilage samples. Histologic and biochemical data thus
validated the clinical classification of the specimens as
CTR and OA14,17.Quantification of mRNA levels
RNA for these analyses was isolated according to
Protocol 3 from undigested, non-fixed cartilage samples. Ct
values for GAPDH from comparable amounts of different
tissue samples displayed a standard deviation lower than
7%, thus ruling out the possibility of extensive RNA degra-
dation or reduced efficiency in cDNA synthesis for selected
specimens. The levels of expression of all the target genes,
normalized to GAPDH, are reported in Table II(C). The
average expression of collagen types I, II, versican and
osteopontin was markedly higher in OA than in CTR
cartilage (3050.6, 6.3, 17.2 and 6.4-fold, respectively).
However, only up-regulation of osteopontin in OA
specimens was statistically significant (P<0.015). mRNA
average levels for collagen type X and aggrecan were
comparable in OA and CTR cartilage. Osteocalcin mRNA
was detected at trace levels only in one OA sample (data
not shown). In both normal and OA cartilage, collagen
types I and II, aggrecan and versican mRNA levels dis-
played large variability. Ratios of collagen type II to I
(CII/CI) and of aggrecan to versican (Agg/Ver), defined as
chondrocyte differentiation indexes, displayed in both
populations more limited differences than single target
genes [Table II(D)]. These indexes were markedly higher in
CTR than in OA cartilage (27.0 and 7.6-fold, respectively),
with high statistical significance (P=0.00013 and
P=0.00007, respectively).Fig. 1. Typical amplification, standard and efficiency curves
obtained by real-time PCR. (A) Amplification plots for GAPDH after
serial dilutions of cDNA, starting from 1 (undiluted, leftmost curve)
to 0.0078 (1:128 dilution, rightmost curve). Ct is defined as the
fractional cycle number at which the fluorescent signal reaches
the selected threshold (indicated by a dotted line). Plots are the
average of two replicates. In the graph, values lower than 0.001
were set to 0.001. (B) Standard curve for GAPDH, plotting the Ct
measured as described above vs the starting cDNA amount. (C)
Efficiency curve for GAPDH, plotting the measured increase in Ct
after each 1:2 dilution (Ct) vs the expected increase in Ct (i.e. the
logarithm in base 2 of the dilution factor). The amplification
efficiency for each target sequence (Et) was calculated as the
slope of the best linear fit of the corresponding efficiency curve
(e.g. 0.965 in this case). An efficiency of 1 (or 100%) would
correspond to one additional cycle required to reach the same
threshold after a 1:2 dilution.Discussion
In this paper we describe for the first time the develop-
ment and validation of real-time PCR assays to quantify
gene expression in human cartilage tissue. The method
allows quantification of levels of ECM gene expression
averaged among all cartilage layers, and is thus com-
plementary to in-situ hybridization techniques, providing
semi-quantitative assessment of the spatial distribution of
collagen and proteoglycan mRNAs2,3,6. As compared to
other techniques currently available for RNA analysis from
whole cartilage specimens, however, real-time PCR is
more sensitive than Northern blotting, requires smaller
tissue samples, possesses a wider dynamic range and has
a higher sample throughput. Most importantly, this tech-
nique makes RNA quantitation more precise and reproduc-
ible than conventional PCR, because it is based on Ct
values established in the early exponential phase of the
PCR reaction, when none of the reagents is rate-limiting,
rather than end-point measurement of the amount of
accumulated product11.
Our main finding was that expression of the genes
encoding collagen types I and II and aggrecan and versican
was highly variable and not significantly different in
chondrocytes obtained from CTR or OA cartilage samples,
whereas ratios of collagen type II to I (CII/CI) and of
aggrecan to versican (Agg/Ver), defined as indexes of cell
differentiation, were significantly higher in CTR than OA
cartilage. The cartilage specimens included in the CTR
group had relatively high Mankin’s scores. In addition, the
majority of them was from a different joint as compared to
the OA cases (i.e. mostly from hip joints as opposed to
knee joints). Nevertheless, the statistical significance for
the difference in the CII/CI and Agg/Ver ratios in the two
experimental groups was remarkable. Our result, then,
suggests a clear general behaviour of OA chondrocytes,
i.e. the tendency to repair cartilaginous injuries by forming a
Osteoarthritis and Cartilage Vol. 9 No. 2 117Table II
Analysis of different cartilage specimens
A B C D
Group/
joint Age
Mankin’s
score
Water
%ww
GAG
%ww
CII
%ww CI CII CX Agg Ver OP CII/CI Agg/Ver
CTR
Hip 72 0.3 74.62 4.24 19.02 0.146 19.9 0.000 0.75 0.004 0.00 136.3 186.8
Hip 73 0.3 73.67 6.11 13.36 0.032 19.7 0.036 1.93 0.016 2.39 615.6 120.6
Hip 66 2.0 73.63 4.64 12.20 0.036 4.4 0.032 0.64 0.014 3.15 123.2 47.0
Hip 85 1.7 71.14 4.10 13.08 0.026 11.6 0.000 0.54 0.004 0.14 444.2 135.9
Hip 67 0.7 70.55 5.41 14.35 0.116 26.0 0.000 0.61 0.010 0.50 224.5 61.4
Ankle 25 1.7 74.46 5.52 17.12 0.158 44.0 0.088 1.15 0.008 1.62 278.2 144.0
Ankle 27 3.3 74.71 3.50 11.63 0.149 35.8 0.063 0.84 0.014 0.37 239.9 58.5
Mean 59.3 1.4 73.25 4.79 14.39 0.095 23.0 0.031 0.92 0.010 1.17 294.6 107.7
Stderr 8.9 0.4 0.65 0.35 1.02 0.023 5.14 0.013 0.18 0.002 0.47 66.9 20.0
OA
Knee 87 7.7 75.50 3.74 9.05 1.63 6.5 0.029 0.16 0.022 6.13 4.0 7.3
Knee 83 7.7 83.56 2.40 5.37 0.08 1.3 0.048 0.16 0.016 7.52 16.5 9.9
Knee 83 8.3 77.46 0.97 12.96 113.40 53.6 0.069 0.46 0.200 18.57 0.5 2.3
Knee 78 4.3 81.46 2.11 4.37 8.11 58.9 0.005 1.09 0.148 0.66 7.3 7.4
Knee 61 8.0 85.19 3.23 4.59 10.52 393.4 0.003 1.48 0.037 0.82 37.4 40.2
Knee 63 8.3 80.71 3.29 7.66 1722.20 103.4 0.000 0.81 0.727 6.32 0.1 1.1
Ankle 66 7.7 80.72 2.91 10.67 453.51 233.1 0.035 1.14 0.331 9.32 0.5 3.4
Ankle 55 4.0 79.58 3.92 5.75 6.23 173.7 0.037 1.70 0.046 11.16 27.9 37.0
Hip 71 8.3 80.17 3.84 7.01 11.85 87.8 0.000 0.31 0.024 0.52 7.4 12.6
Hip 56 6.3 77.93 4.76 12.39 282.40 196.3 0.030 0.27 0.019 12.55 0.7 14.1
Mean 68.4 7.0 80.75 3.05 7.86 289.81 144.6 0.025 0.82 0.172 7.49 10.9 14.2
Stderr 3.7 0.5 0.90 0.34 1.00 169.43 38.2 0.007 0.18 0.071 1.85 4.1 4.4
P value* 0.22 0.000001 0.00004 0.005 0.00057 0.222 0.035 0.69 0.543 0.109 0.015 0.00013 0.00007
The mean (Mean) and standard error (Stderr) are reported for each group, along with the statistical P-value for the difference between the
two groups.
A: Classification of cartilage samples as control (CTR) or osteoarthritic (OA) was based on clinical and radiological evaluation12.
B: Biochemical assessment: wet weight fractions of water, glycosaminoglycans (GAG), and type II collagen (CII).
C: mRNA expression normalized to GAPDH of collagen types I (CI), II (CII), and X (CX), aggrecan (Agg), versican (Ver), and osteopontin
(OP). RNA used for these experiments was extracted using silica-gel-based membranes and displayed relatively high purity (OD260/OD280
around 2.0).
D: Ratios of mRNA expression levels of collagen type II to I (CII/CI) and of aggrecan to versican (Agg/Ver).
*Bold type indicates statistically significant difference between the CTR and OA groups (P<0.02).fibrocartilaginous tissue rather than hyaline cartilage, con-
sistent with the ultimate structural and functional degener-
ation of cartilage tissue observed in late stages of OA17.
Among the markers of chondrocyte hypertrophy, we
investigated the expression of collagen type X and osteo-
pontin. In contrast to previous reports2,5, in some of the
CTR samples we detected collagen type X mRNA. This
finding may be explained by the higher sensitivity of real-
time PCR as compared to in-situ hybridization, and is
consistent with the immunolocalization of collagen type X in
the surface layers of normal adult cartilage18. We then
observed that the expression of type X collagen in the OA
cartilage samples was not increased as compared to the
CTR group. This result, also apparently in contrast to
previous reports, can be explained by the fact that our
specimens did not include the calcified cartilage layer, in
contact with the subchondral bone, where collagen type X
expression was found increased during OA2,5. Interest-
ingly, osteopontin was significantly upregulated in OA
specimens. The expression of osteopontin gene during
chondrocyte maturation is known to be one of the key
events involved in cartilage-to-bone transition in fracture
repair19, and it was shown to be increased in chondrocytes
exposed to IL-1 in vitro20. However, the expression of
osteopontin gene in normal and OA human articular
cartilage has not been previously reported.Reliable and reproducible PCR amplification curves
were obtained only if RNA was extracted and purified on
silica-gel membranes (protocol 3). The insufficiently pure
material yielded by the typical one-step RNA extraction
technique (protocol 1) and the non-reproducible amplifica-
tions obtained with an additional purification step (protocol
2) can be explained by the large amounts of ECM proteins
in cartilage tissue possibly interfering with the extraction
procedure and/or inhibiting the DNA polymerase. We also
report that cartilage incubation with collagenase induces
rapid changes in chondrocyte gene expression, implying
that RNA analysis should not be performed on isolated cells
after tissue digestion. The finding that the method can be
applied after cartilage fixation in acetone is consistent
with previous reports related to lymphoid tissue21, and
opens the possibility of quantifying gene expression in
specific regions of native cartilage, selected by histologic or
immunohistochemical analysis.
The use of real-time PCR to quantify gene expression in
cartilage tissue may be extended to the analysis of different
inflammatory cytokines and degradative enzymes involved
in the process of OA in order to identify additional quanti-
tative patterns of gene expression, not only related to ECM
proteins and to cell differentiation. An extension of the
assays in this direction might lead to an explanation of the
large variability found among OA samples in the expression
118 I. Martin et al.: Real-time PCR of human cartilageof ECM genes, particularly collagen types I and II, and
possibly to correlate it with different stages/modalities of the
pathology. The method described here may thus help to
elucidate the complex mechanisms involved in cartilage
degeneration and, given the high level of intra- and inter-
laboratory standardization it can provide, it may become a
valuable diagnostic tool to detect early changes in potential
OA patients. The assays developed in this paper and the
defined differentiation indexes can also be used to quantify
ECM gene expression in cultured chondrocytes, and thus
improve the understanding of the effects of different regu-
latory molecules in the process of chondrocyte de- and
redifferentiation.Acknowledgments
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